Tradestie Institutional Equity Comparison Engine

TERN vs ANL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TERN Overall Edge

TERN Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Terns Pharmaceuticals, Inc. Common Stock (TERN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TERN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ANL at N/M Forward P/E and -123.5% operating margin (+178.1% YoY). In options structure, TERN sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against ANL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
TERN N/M vs ANL N/M Fwd P/E
Growth & Margin Winner TERN
Op Margin 0.0% vs -123.5% ยท YoY +0.0% vs +178.1%
Momentum & Technical Winner TERN
1Y +1387.4% vs +560.3% ยท 52W Pos 100% vs 56%
Options & Structure Winner TERN
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
TERN NASDAQ
Terns Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$52.95
+0.04% 1D
Market Cap $6.1B
1M Return +0.44%
1Y Return +1387.36%
Forward P/E N/M
Unified AI Score
51.9 / 100 HOLD
Tech 40.0 Fund 42.0 Flow 60.0 Mom 21.1
ANL US Equity
ANL
Institutional Equity
$9.97
-6.03% 1D
Market Cap $677.5M
1M Return -9.61%
1Y Return +560.26%
Forward P/E N/M
Unified AI Score
48.3 / 100 HOLD
Tech 48.0 Fund 52.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TERN +1387.36% ANL +560.26% Spread: +735.96 pp (ANL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TERN TTM Op. Margin: 0.0% ANL TTM Op. Margin: -123.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TERN vs ANL. Trailing 12-month operating profitability (TERN 0.0% vs ANL -123.5%) and valuation multiples (TERN N/M vs ANL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TERN (7) vs ANL (1)
Institutional Metric TERN ANL Criterion Row Winner
Market Capitalization Scale $6.1B $677.5M Larger Scale TERN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +178.1% Higher Growth ANL
Operating Margin (TTM) Profitability 0.0% -123.5% Higher Margin TERN
Net Profit Margin Profitability 0.0% -124.8% Higher Margin TERN
Return on Equity (ROE) Capital Efficiency -14.2% -20.2% Higher ROE TERN
52-Week Range Position Momentum 100% ($3โ€“$53) 56% ($1โ€“$17) Stronger Trend TERN
Beta / 30D Volatility Risk Regime 0.07ฮฒ ยท 2% Vol 2.61ฮฒ ยท 79% Vol Lower Realized Risk TERN
Unified Institutional Score Composite Signal 51.9 / 100 (HOLD) 48.3 / 100 (HOLD) Higher Composite TERN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TERN vs ANL Buy Guide
TERN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live TERN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ANL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TERN nor ANL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.